Circadian Rest-activity Rhythm in Chronic Obstructive Pulmonary Disease
Overview
Authors
Affiliations
To characterize circadian rest-activity rhythm in COPD, 26 cases (66.9 ± 8.5y) and 15 controls (63.0 ± 10.7y) were assessed by actimetry. Rhythm fragmentation was measured by intradaily variability (IV), while synchronization to the 24-h light-dark cycle was measured by interdaily stability (IS). The average activity during the least active 5-h period (L5) and the average activity during the most active 10-h period (M10) were used to calculate the relative amplitude mean [RAm = (M10-L5)/(M10+L5)]. COPD patients presented higher IVm (0.242 ± 0.097 vs 0.182 ± 0.063) and L5 (36.849 ± 18.239 vs 19.888 ± 12.268) and lower RAm (0.696 ± 0.134 vs 0.833 ± 0.093) than controls. Future studies on the effects of chronotherapy measures in COPD are warranted.
Liu L, Tang Z, Zeng Q, Qi W, Zhou Z, Chen D J Inflamm Res. 2024; 17:2873-2887.
PMID: 38741612 PMC: 11090121. DOI: 10.2147/JIR.S458580.
Jun J, Park C, Fritschi C, Balserak B, Martyn-Nemeth P, Kuna S Heart Lung. 2023; 64:6-13.
PMID: 37976563 PMC: 10947945. DOI: 10.1016/j.hrtlng.2023.11.001.
Gouldthorpe C, Ancoli-Israel S, Cash E, Innominato P, Jakobsen G, Levi F Cancers (Basel). 2023; 15(15).
PMID: 37568600 PMC: 10416864. DOI: 10.3390/cancers15153784.
Huang B, Liao G, Yi Lee P, Chan C, Tai L, Tsang C Sci Rep. 2023; 13(1):1650.
PMID: 36717700 PMC: 9885413. DOI: 10.1038/s41598-023-28832-5.
Swanson G, Kochman N, Amin J, Chouhan V, Yim W, Engen P Front Med (Lausanne). 2022; 8:770491.
PMID: 35265631 PMC: 8900134. DOI: 10.3389/fmed.2021.770491.